Surfactant protein-B and lung function in surfactant-treated preterm lambs

Area of Science:

• Neonatal Physiology
• Pulmonary Surfactant Research

Background:

• Preterm birth complications often involve respiratory distress syndrome.
• Pulmonary surfactant, particularly surfactant protein B (SP-B), is crucial for lung function.
• Understanding the dose-response relationship of SP-B in exogenous surfactant is vital for optimizing treatment.

Purpose of the Study:

• To investigate the correlation between the amount of SP-B in exogenous surfactant and postnatal lung function in preterm lambs.
• To assess the SP-B content in recovered surfactant after ventilation.
• To evaluate the impact of varying SP-B concentrations on lung injury markers.

Main Methods:

• Exogenous surfactant with varying SP-B concentrations (37-410 µg/mL) was administered to preterm lambs (123 days gestation).
• Lambs underwent ventilation using a low tidal volume strategy to minimize lung injury.
• Postnatal lung function (compliance, lung volume) and SP-B content in alveolar washes were measured after 10 hours.

Main Results:

• A linear correlation was observed between administered SP-B and recovered SP-B (r = 0.95, p < 0.001).
• Small increases in lung compliance were noted with SP-B > 37 µg/mL.
• Increased lung volume was observed with 385 µg/mL SP-B compared to 37 µg/mL SP-B.
• Low levels of albumin leak and total protein in alveolar washes indicated minimal lung injury.

Conclusions:

• The amount of SP-B in exogenous surfactant had minimal effects on postnatal lung function in preterm lambs over a 10-hour period.
• While SP-B levels correlated with recovery, significant functional improvements were not consistently demonstrated within the study parameters.
• The findings suggest that within the tested range and ventilation strategy, SP-B concentration plays a limited role in short-term lung function outcomes.